Biohaven Ownership | Who Owns Biohaven?
Biohaven Ownership Summary
Biohaven is owned by 3.93% institutional investors, 11.96% insiders, and 84.11% retail investors. Vanguard group is the largest institutional shareholder, holding 8.92% of BHVN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.68% of its assets in Biohaven shares.
BHVN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Biohaven | 3.93% | 11.96% | 84.11% |
| Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
| Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 8.41M | 8.92% | $314.27M |
| Blackrock | 6.17M | 7.56% | $214.15M |
| Janus henderson group | 6.98M | 7.40% | $260.73M |
| Blackrock funding, inc. /de | 7.54M | 7.36% | $106.32M |
| Stifel financial | 6.56M | 6.95% | $244.99M |
| Suvretta capital management | 5.62M | 5.49% | $79.30M |
| State street | 3.51M | 3.72% | $131.19M |
| Price t rowe associates inc /md/ | 3.41M | 3.62% | $127.45M |
| Rp management | 2.94M | 3.11% | $146.74M |
| Bellevue group | 2.80M | 2.74% | $39.55M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Rp management | 2.94M | 64.43% | $146.74M |
| Oracle investment management | 673.17K | 6.51% | $9.50M |
| 5am venture management | 478.97K | 4.27% | $17.89M |
| Lion point capital, lp | 22.70K | 3.48% | $545.71K |
| Bison wealth | 332.43K | 2.74% | $12.42M |
| Suvretta capital management | 5.62M | 2.39% | $79.30M |
| Prosight management, lp | 539.07K | 1.85% | $7.61M |
| Pfizer | 505.64K | 1.24% | $7.13M |
| Ars investment partners | 1.19M | 1.22% | $16.76M |
| Redmile group | 729.51K | 1.10% | $10.29M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Voloridge investment management | 1.44M | 0.07% | 1.29M |
| Jpmorgan chase | 1.98M | 0.01% | 1.17M |
| Norges bank | 902.57K | 0.00% | 902.57K |
| Millennium management | 901.26K | 0.01% | 895.46K |
| Bellevue group | 2.80M | 0.87% | 762.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Farallon capital management | - | - | -4.81M |
| Perceptive advisors | - | - | -1.49M |
| Darwin global management | - | - | -1.48M |
| Point72 asset management | - | - | -922.97K |
| Hood river capital management | - | - | -783.67K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 902.57K | 0.00% | 902.57K | $33.71M |
| Logos global management lp | 700.00K | 1.09% | 700.00K | $9.88M |
| Capital research global investors | 484.19K | 0.00% | 484.19K | $6.83M |
| Artal group | 306.70K | 0.27% | 306.70K | $10.65M |
| Tudor investment corp et al | 145.25K | 0.00% | 145.25K | $2.05M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -1.00 |
| Allspring global investments | -2.00 |
| Gps wealth strategies group | -5.00 |
| Fortitude family office | -5.00 |
| Jfs wealth advisors | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 20 | -92.51% | 4,003,493 | -95.66% | 3 | 0.04% | 9 | -94.12% | 7 | -89.23% |
| Dec 31, 2024 | 107 | -59.62% | 28,793,137 | -66.29% | 30 | 0.37% | 63 | -53.33% | 20 | -73.68% |
| Sep 30, 2024 | 263 | 11.91% | 85,395,678 | 3.25% | 90 | 1.02% | 133 | -5.00% | 76 | 43.40% |
| Jun 30, 2024 | 233 | -11.74% | 82,690,329 | 11.42% | 101 | 1.23% | 139 | 6.11% | 51 | -30.14% |
| Mar 31, 2024 | 264 | 14.29% | 74,214,259 | 2.75% | 90 | 0.88% | 131 | -2.24% | 73 | 46.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.83M | 2.68% | -62.83K |
| Vanguard US Total Market Shares ETF | 2.43M | 2.38% | 217.08K |
| BB Biotech AG Ord | 2.04M | 2.02% | - |
| iShares Russell 2000 ETF | 2.12M | 2.00% | -40.22K |
| Vanguard Small Cap Index | 2.11M | 1.99% | -14.23K |
| T. Rowe Price Health Sciences | 1.71M | 1.67% | 51.32K |
| SPDR® S&P Biotech ETF | 1.47M | 1.44% | 36.24K |
| Vanguard Small Cap Value Index Inv | 1.36M | 1.29% | 6.87K |
| HBM Healthcare Investments AG Ord | 1.13M | 1.11% | 130.00K |
| Fidelity Select Biotechnology | 1.04M | 1.02% | 24.80K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 04, 2025 | CHILDS JOHN W | - | Buy | $104.47K |
| Mar 04, 2025 | CHILDS JOHN W | - | Buy | $104.47K |
| Mar 04, 2025 | CHILDS JOHN W | - | Buy | $759.65K |
| Mar 04, 2025 | CHILDS JOHN W | - | Buy | $27.65K |
| Apr 22, 2024 | CHILDS JOHN W | - | Buy | $3.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | 4 | - |
| 2024 Q4 | 3 | - |
| 2024 Q3 | 2 | - |
| 2024 Q2 | 10 | - |
BHVN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools